<DOC>
	<DOC>NCT01554631</DOC>
	<brief_summary>To establish the bioequivalence between Glucobay ODT (Orally Disintegrating Tablet) 100 mg taken without or with water and the Glucobay standard tablet 100 mg taken with water.</brief_summary>
	<brief_title>A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Healthy male subject Age: 18 to 45 years (inclusive) at the first screening examination / visit Ethnicity: White Body mass index (BMI): above/equal 18 and below/equal 28 kg / m² Incompletely cured preexisting diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal Subjects with a medical disorder, condition or history of such that would impair the subject's ability to participate or complete this study in the opinion of the investigator or the sponsor Known hypersensitivity to the study drugs (active substances or excipients of the preparations) Known severe allergies, nonallergic drug reactions, or multiple drug allergies Chronic intestinal disorders associated with distinct disturbances of digestion and absorption States which may deteriorate as a result of increased gas formation in the intestine (e.g. Roemheld´s syndrome, major hernias, intestinal obstructions, intestinal ulcers, Crohn´s disease, ulcerative colitis, malabsorptions) Fasting blood glucose level outside normal range Impaired glucose tolerance in glucose tolerance test</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Acarbose</keyword>
	<keyword>ODT</keyword>
</DOC>